REPORT ID 2767

EMEA (Europe, Middle East and Africa) Recombinant Coagulation Factors Market Report 2019

Publish Date
2019
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Recombinant Coagulation Factors market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Recombinant Coagulation Factors for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Recombinant Coagulation Factors market competition by top manufacturers/players, with Recombinant Coagulation Factors sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Novo Nordisk
    Bayer
    Baxter International
    Grifols International
    CSL Ltd
    Kedrion
    Octapharma AG
    Biogen Idec

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Recombinant Factor VIII
    Recombinant Factor IX
    Von Willebrand Factor
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Research Organizations
    Academic Institutes
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Recombinant Coagulation Factors Market  Report 2019
1 Recombinant Coagulation Factors Overview
    1.1 Product Overview and Scope of Recombinant Coagulation Factors
    1.2 Classification of Recombinant Coagulation Factors
        1.2.1 EMEA Recombinant Coagulation Factors Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Recombinant Coagulation Factors Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Recombinant Factor VIII
        1.2.4 Recombinant Factor IX
        1.2.5 Von Willebrand Factor
        1.2.6 Other
    1.3 EMEA Recombinant Coagulation Factors Market by Application/End Users
        1.3.1 EMEA Recombinant Coagulation Factors Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Organizations
        1.3.5 Academic Institutes
        1.3.6 Other
    1.4 EMEA Recombinant Coagulation Factors Market by Region
        1.4.1 EMEA Recombinant Coagulation Factors Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Recombinant Coagulation Factors ( 2014-2024)
        1.5.1 EMEA Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Recombinant Coagulation Factors Revenue and Growth Rate ( 2014-2024)

2 EMEA Recombinant Coagulation Factors Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Recombinant Coagulation Factors Market Competition by Players/Manufacturers
        2.1.1 EMEA Recombinant Coagulation Factors Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Recombinant Coagulation Factors Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Recombinant Coagulation Factors Sale Price by Players ( 2014-2019)
    2.2 EMEA Recombinant Coagulation Factors (Volume and Value) by Type/Product Category
        2.2.1 EMEA Recombinant Coagulation Factors Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Recombinant Coagulation Factors Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Recombinant Coagulation Factors Sale Price by Type ( 2014-2019)
    2.3 EMEA Recombinant Coagulation Factors (Volume) by Application
    2.4 EMEA Recombinant Coagulation Factors (Volume and Value) by Region
        2.4.1 EMEA Recombinant Coagulation Factors Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Recombinant Coagulation Factors Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Recombinant Coagulation Factors Sales Price by Region ( 2014-2019)

3 Europe Recombinant Coagulation Factors (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Recombinant Coagulation Factors Sales and Value ( 2014-2019)
        3.1.1 Europe Recombinant Coagulation Factors Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Recombinant Coagulation Factors Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Recombinant Coagulation Factors Sales and Market Share by Type
    3.3 Europe Recombinant Coagulation Factors Sales and Market Share by Application
    3.4 Europe Recombinant Coagulation Factors Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Recombinant Coagulation Factors Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Recombinant Coagulation Factors Revenue by Countries ( 2014-2019)
        3.4.3 Germany Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        3.4.4 France Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)

4 Middle East Recombinant Coagulation Factors (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Recombinant Coagulation Factors Sales and Value ( 2014-2019)
        4.1.1 Middle East Recombinant Coagulation Factors Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Recombinant Coagulation Factors Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Recombinant Coagulation Factors Sales and Market Share by Type
    4.3 Middle East Recombinant Coagulation Factors Sales and Market Share by Application
    4.4 Middle East Recombinant Coagulation Factors Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Recombinant Coagulation Factors Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Recombinant Coagulation Factors Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)

5 Africa Recombinant Coagulation Factors (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Recombinant Coagulation Factors Sales and Value ( 2014-2019)
        5.1.1 Africa Recombinant Coagulation Factors Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Recombinant Coagulation Factors Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Recombinant Coagulation Factors Sales and Market Share by Type
    5.3 Africa Recombinant Coagulation Factors Sales and Market Share by Application
    5.4 Africa Recombinant Coagulation Factors Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Recombinant Coagulation Factors Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Recombinant Coagulation Factors Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Recombinant Coagulation Factors Sales and Growth Rate ( 2014-2019)

6 EMEA Recombinant Coagulation Factors Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Recombinant Coagulation Factors Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Novo Nordisk
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Recombinant Coagulation Factors Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novo Nordisk Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Bayer
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Recombinant Coagulation Factors Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bayer Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Baxter International
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Recombinant Coagulation Factors Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Baxter International Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Grifols International
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Recombinant Coagulation Factors Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Grifols International Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 CSL Ltd
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Recombinant Coagulation Factors Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 CSL Ltd Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Kedrion
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Recombinant Coagulation Factors Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Kedrion Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Octapharma AG
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Recombinant Coagulation Factors Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Octapharma AG Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Biogen Idec
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Recombinant Coagulation Factors Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Biogen Idec Recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview

7 Recombinant Coagulation Factors Manufacturing Cost Analysis
    7.1 Recombinant Coagulation Factors Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Recombinant Coagulation Factors

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Recombinant Coagulation Factors Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Recombinant Coagulation Factors Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Recombinant Coagulation Factors Market Forecast ( 2019-2025)
    11.1 EMEA Recombinant Coagulation Factors Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Recombinant Coagulation Factors Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Recombinant Coagulation Factors Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Recombinant Coagulation Factors Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Recombinant Coagulation Factors Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Recombinant Coagulation Factors Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Recombinant Coagulation Factors Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Recombinant Coagulation Factors Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Recombinant Coagulation Factors Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Recombinant Coagulation Factors Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer